Stoke Therapeutics, Inc.
STOKPharmaceutical Preparations · SIC 2834 · CIK 0001623526
Revenue FY2025
$184.0M
Net Income
$(7.0M)
EPS (Basic)
$-0.12
Net Margin
-3.7%
ROE
-2.0%
Total Equity
$352.0M
Shares Out
65M
Stoke Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 4 funds in our universe
Insider Transactions
Reading stored insider transactions…